This website intends to use cookies to improve the site and your experience. Integrated Annual Report 2019 summary - German (pdf, 9.33 MB) Sustainability performance report 2019 (pdf, 5.01 MB) Integrated Profit and Loss Statement (IP&L) (pdf, 751.67 KB) GRI Content Index 2019 (pdf, 155.16 KB) Materiality Review 2019 (pdf, 1.25 MB) Glossary of non-GAAP measures. Elmos Semiconductor SE Heinrich-Hertz-Straße 1 44227 Dortmund Phone: +49 (0) 231 / 75 49-0 Fax: +49 (0) 231 / 75 49-149 info[at]elmos.com “Item 5. The Annual Review explains who we are and what we do, and highlights our progress against the company Form 20-F documents Novartis results in line with requirements of the US Securities and Exchange Commission (SEC). Our Annual Report 2019 provides a comprehensive overview of Novartis, including our corporate governance, compensation practices, and operating and financial results. The Group Development operating segment also included the 12 percent financial stake in BT until March 23, 2018, when it was transferred to Deutsche Telekom Trust e.V. Novartis erzielt 2019 ein starkes Umsatzwachstum, Margen- steigerungen und bahnbrechende Innovationen mit der Markt- einführung fünf neuer Wirkstoffe Der Nettoumsatz der fortzuführenden Geschäftsbereiche1steigt 2019 um 9% (kWk2, +6% USD): o Die Geschäftseinheit Pharmaceuticals wächst um 12% (kWk), getragen von Cosentyx Swiss Prime Site ended the 2019 financial year with very positive results. Die Einführung neuer Produkte sowie die Konzentration auf Kostendis- ziplin und betriebliche Effizienz haben uns geholfen, den Umsatz, das operative Ergebnis und die operative Gewinnmarge zu steigern. as plan assets. An explanation of non-IFRS measures can be found on page 42 of the Condensed Financial Report. By resolution of the Supervisory Board of Deutsche Telekom AG of February 20, 2019, Srini Gopalan was reappointed as the Board of Management member responsible for Europe for the period from January 1, 2020 to December 31, 2024. 3. Annual report 2019 [PDF] The 2019 Annual Report offers a detailed insight into the business performance of Deutsche Börse Group. Refers to continuing operations as defined on page 45 of the Condensed Financial Report, excludes Alcon, includes the businesses of Innovative Medicines and Sandoz (including the US generic oral solids and dermatology portfolio), as well as the continuing corporate functions. The Annual Review explains who we are and what we do, and highlights our progress against the company’s five strategic priorities in 2019. September 2019). Unless otherwise noted, all growth rates in this Release refer to same period in prior year. We achieved top-line growth and leveraged our financial strength to make significant, bold investments in initiatives to drive long-term growth. We successfully launched Children’s TYLENOL Dissolve Packs, a novel way to administer pain relief for children. Lesen Sie die wichtigsten Konzernpublikationen online oder bestellen Sie sich eine gedruckte Version bequem nach Hause. Compare Novartis financial and non-financial key performance indicators This website intends to use cookies to improve the site and your experience. An explanation of non-IFRS measures can be found on page 58 of the Condensed Financial Report. By continuing to browse the site you are agreeing to accept our use of cookies. Deutsche Telekom – Das Geschäftsjahr 2019 Konzern-Bilanz – Aktiva in Mio. Unless otherwise noted, all growth rates in this Release refer to same period in prior year.2. Documents Novartis results in XML format in line with requirements of the US Securities and Exchange Commission (SEC). This site is intended for a global audience. COMPENSATION REPORT – EDITORIAL DR. BARBARA FREI-SPREITER 4 «Agile and flexible into the future» Agility and flexibility are two key virtues these days. Hier finden Sie eine Übersicht aller Geschäftsergebnisse des letzten Kalenderjahres. An explanation of non-IFRS measures can be found on page 53 of the Condensed Financial Report. 1. Jan 29, 2020. Markiert: Berkshire Hathaway Geschäftsbericht 2019 6 AktienAutor / Berkshire Hathaway Inc. / Blogartikel / Branche / Empfehlung / Kaufen / Nachkaufalarm / S&P500 / Update 26. 2 | Novartis Geschäftsbericht 2017 Brief des Präsidenten des Verwaltungsrats Liebe Aktionärin, lieber Aktionär Novartis hat 2017 substanzielle Fortschritte gemacht. These presentations remain on the Novartis website for historical purposes only. Usage Rights & Restrictions . Willkommen auf den Seiten der Novartis Austria GmbH Anlässlich des Welttags des Sehens wollen wir auf die feuchte altersabhängige Makuladegeneration aufmerksam machen. Novartis AG and its consolidated affiliates publish consolidated financial statements expressed in US dollars. Geschäftsbericht 2019 Einfach durch den Geschäftsbericht Der Umwelt zuliebe ERZ spart mit diesem digitalen Dokument pro Ausgabe rund 1,4 t Papier ein. Juli 2020 Medienmitteilung (PDF 0.2 MB) Zwischenbericht für das zweite Quartal 2020 (PDF 0.8 This site is intended for a global audience. It is restricted for other purposes. New product launches together with a disciplined focus on costs and operational efficiency helped us increase sales, operating income and operating profit margin. You can explore the main chapters and sub-chapters using the navigation bar at … GESCHÄFTSBERICHT 2019 VARTA AG KONZERNLAGEBERICHT Im Rahmen dieser Anpassung wurde einer der beiden Vorstandsverträge im November 2019 von einer ursprüng- lich auf fünf Jahre ausgelegten, langfristigen aktienbasierten Vergütung auf eine auf drei Jahre ausgelegte Wert- zuwachsvergütung angepasst. Veröffentlicht am 22.10.2019 7 CORPORATE GOVERNANCE – CAPITAL STRUCTURE Disclosure notifications of major shareholders Information regarding major shareholders is based on the register of shareholders or the notifications received by Swiss Prime Site AG. GESCHÄFTSBERICHT 2019 2 Mission: Unsere Kompetenz – damit Sie Heilmitteln vertrauen können. Bank Cler – Geschäftsbericht 2019 4 Bilanz 31.12.2019 31.12.2018 Bilanzsumme in 1000 CHF 18 815 719 17 900 140 • Veränderung in % 5,1 2,2 Kundenausleihungen in 1000 CHF 15 983 866 15 455 757 • … Novartis Institutes for BioMedical Research. Alcon shareholders may receive a hard copy of Alcon’s 2019 Annual Report or its 2019 Annual Report on Form 20-F filed with the US Securities and Exchange Commission, each of which contains our complete audited financial statements, free of charge, upon request. Geschaeftsbericht 2019_Englisch 7 24.02.2020 15:14:36. The integration of post-acute care facilities in Germany has been successfully completed and further strengthens our service business. Core businesses in pharmaceuticals, vaccines, consumer health, generics and animal health. EEX Group Geschäftsbericht 2019 3 Global Report Gesellschaftliche Verantwortung Management Gastbeitrag Konzernlagebericht Konzernabschluss Report Success Report 2019 2018 Veränderung in % Gewinn- und Verlust-Rechnung Umsatzerlöse T€ 304.212 267.654 +14 Ergebnis vor Zinsen, Steuern und Abschreibungen (EBITDA) T€ 121.116 111.612 +9 Watch the media webcast … Unless otherwise noted, all growth rates in this Release refer to same period in prior year. Webcasts Media. In 2019, we took another step closer to becoming carbon-neutral in our own operations by the end of 2020, with both our US and Dutch facilities now 100%-powered by renewable energy. Q4 … Constant currencies (cc), core results and free cash flow are non-IFRS measures. 2019 Quarterly Results. 2019 was dominated by the climate crisis and worldwide protests about climate policy. Neun Monate 2020 Präsentation mit Anhang. The fact that we did this even though 2019 was another relatively costly year for the reinsurance industry merely underlines our profitability. View recent presentations and learn more about upcoming events, Investors International:Call +41 61 324 79 44, Investors North America:Call +1 862 778 5052, Novartis Share Registry:For information relating to the registration of your shares, including name or address changes, please contact us by e‑mail or telephone:Call +41 61 324 72 04. Pkm 1) 2019 A 32,7 2018 A A33,3 2017 A 33,3 2016 A 32,6 2015 A 34,7 w 2019 zu 2018: – 1,8 % Ergebnis nach Steuern 2) — in Mio. Financial Publication . « Jean-Jacques Henchoz Chairman of the Executive Board Foreword. Letter from the CEO Niels B. Christiansen CEO, the LEGO Group We outpaced the toy industry and took steps How medicines are making an impact in the lives of patients. Find Novartis annual results, including media releases, annual reports, webcasts and presentations, and year-to-date figures. 9M 2020; HY 2020; Q1 2020; FY 2019; Alle; Neun Monate 2020 Investor update. This media asset is free for editorial broadcast, print, online and radio use. Q3 2019 Media Release (PDF 0.1 MB) Q3 2019 Financial Report (PDF 0.8 MB) Q2 2019 Media Release (PDF 0.2 MB) Q2 2019 Financial Report (PDF 0.6 MB) Q1 2019 Media Release (PDF 0.5 MB) Q1 2019 Financial Report (PDF 0.5 MB) 2018 Quarterly Results. Constant currencies (cc), core results and free cash flow are non-IFRS measures. € für den Cash Capex (vor Investitionen in Spektrum) angepasst (Konzern-Zwischenbericht zum 30. Quartalsberichte; Geschäftsberichte; Hauptversammlung 2020; Geschäftsbericht und Jahresabschluss 2016 pdf Geschäftsbericht und Jahresabschluss 2015 pdf Geschäftsbericht und Jahresabschluss 2014 pdf Konzernabschluss und ausgewählte Anhangsangaben 2014 pdf Geschäftsbericht und Jahresabschluss 2013 pdf Geschäftsbericht und Jahresabschluss … Refers to continuing operations, defined on page 41 of the Condensed Financial Report. Deutsch; Annual Report 2019 » With Group net income of EUR 1.28 billion Hannover Re achieved another record result. Building on decades of pioneering work, the H160 integrates 68 different patented technologies. Hannover Re Group. Constant currencies (cc), core results and free cash flow are non-IFRS measures. Computershare. PUBLICA – Geschäftsbericht 2019 65 163 Versicherte 42 301 Rentenbeziehende 104,1% Deckungsgrad 86,1% Ökonomischer Deckungsgrad CHF 41,0 Mia. Wir konnten Alcon auf den Wachstumspfad zurückfüh-ren und The Novartis in Society ESG Report details progress and demonstrates the company’s commitment in global health and corporate responsibility. 2019 on establishing a clear plan and path to achieve benchmark profitability in 2020, and the segment is already well on its way—as we delivered 90 basis points of adjusted income before tax margin* improvement in 2019. Own capitalized costs amounted to EUR 2.4 billion in the reporting year (2018: EUR 2.4 billion, 2017: EUR  Disclaimer: The information in the presentations on these pages was factually accurate on the date of publication. Our Executive Team talks innovation highlights from the third quarter of 2019 $NVS. Our consolidated financial statements responsive to Item 18 of this Annual Report on Form 20-F (Annual Report) are prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB). Geschäftsbericht 19; Finanzbericht 19; Roche in Kürze 19; Roche im Überblick 19 ; Quartalsergebnisse Archiv. € für das bereinigte EBITDA AL und von rund 12,7 Mrd. Unless otherwise noted, all growth rates in this Release refer to same period in prior year. 2019: +84,5 % Allzeithoch: 127,60 € 229 Neue am Start 713 insgesamt auf dem Weg 9 Bechtle AG Geschäftsbericht 2019 The interactive version of the Digital Annual Review is available here. Geschäftsbericht 2019 Wichtige Kennzahlen Aus der Bilanz in Mrd. 2018 English (PDF 8.6 MB) Before joining Deutsche Bank, he worked at McKinsey & Company in London focusing on a broad range of projects for the financial services industry. Documents Novartis results in XML format in line with requirements of the US Securities and Exchange Commission (SEC). Germany (Deutschland) Deutsch; India English; Italy (Italia) Italiano; Spain (España) Español; United Kingdom English; United States English; Site Search. 1. Bilanzsumme 0,20% Gesamtaufwand für die Verwaltung des Vermögens Contact Alcon Investor Relations +41 589 112 110 +1 817 615 2789 investor.relations@alcon.com. 2. Annual Report and Accounts 2019 Welcome to the Annual Report and Accounts for the year ended December 31, 2019. COMPENSATION REPORT – EDITORIAL DR. BARBARA FREI-SPREITER 3 Geschaeftsbericht 2019_Englisch 3 24.02.2020 15:16:27. mehr. Geschäftsbericht 2019 Entwicklungen im Geschäftsjahr 2019 Verkehrsleistung — in Mrd. Deutsche And Other Scandal-Plagued Banks Should Learn From Novartis, Tenneco, And Volkswagen Mayra Rodriguez Valladares Senior Contributor Opinions expressed by Forbes … Dezember 2019 bezieht, wird in diesem die 8 INTEGRATED REPORT – INTERVIEW WITH THE CEO Geschaeftsbericht 2019_Englisch 8 24.02.2020 15:14:38. a Abweichend von den im zusammengefassten Lagebericht 2018 (Geschäftsbericht 2018) veröffentlichten Prognosen haben wir die Erwartungswerte 2019 unterjährig von rund 23,9 Mrd. Geschäftsbericht 2019 English (PDF 3.8 MB) Novartis in der Schweiz 2020 Deutsch (PDF 2.9 MB) Français (PDF 2.9 MB) English (PDF 2.9 MB) Campus Unternehmensmagazin Novartis, Nr. A very strong order book secures future growth in the project business. Ergebnisse Q2 und Halbjahr 2020 Dienstag, 21. Geschaeftsbericht 2019_Englisch 2 24.02.2020 15:16:24. Novartis SWOT Analysis Novartis Strengths Below are the Strengths in the SWOT Analysis of Novartis: 1.Has a global reach in over 140 countries. Januar bis 31. Setting the benchmark in helicopters Due to enter into service in 2020, the H160 sets the benchmark for helicopter design. Management‘s Review Annual Report 2019 We are very pleased with the progress we made in 2019. See the full letter in our 2019 Integrated Report. Januar 2020 auf den Namen TX Group AG umfirmiert. Our Annual Report 2018 provides a comprehensive overview of Novartis, including our corporate governance, compensation practices, and operating and financial results. LafargeHolcim Half-Year Report 2019. Neun Monate 2020 Präsentation. Media Releases. Sto SE & Co. KGaA | Geschäftsbericht 2019 Erklärung des Titelbildes: Für das neue Papiermuseum in Düren ließ sich der Kölner Architekt Klaus Hollenbeck vom Werkstoff inspirieren – Faltung, Prägung und Wasserzeichen wurden Unless otherwise noted, all growth rates in this Release refer to same period in prior year. Annual report 2019 Deutsche Börse Group: review and outlook. Highlights Geschäftsbericht 2019. The Digital Annual Review 2019 highlights our progress against the company’s five strategic priorities on an interactive page. Download the media release English (PDF 0.1 MB ) | Deutsch (PDF 0.1 MB) | Français (PDF 0.1 MB) Condensed financial report (PDF 0.7 MB) Financial Results 2019 highlights. : +49 40 3334-0 Sentmaringer Weg 1 48151 Münster Tel. An explanation of non-IFRS measures can be found on page 55 of the Condensed Financial Report. Novartis 2019 Financial Results . Novartis announces the company’s fourth quarter and 2019 full year financial results. We know how urgent the situation is: That is why we initiated further decisive steps in the reporting year to strengthen our contribution to fighting climate change. Download the Annual Report 2019 (PDF 3.8 MB), Visit the 2019 Annual Reporting Suite section. € auf rund 24,1 Mrd. In 2019, we recorded excellent sales development of 31% and organic sales growth of 16%. Download Centre. Weil sich der vorliegende Geschäftsbericht jedoch auf das Geschäftsjahr vom 1. Eckert & Ziegler Geschäftsbericht 2019 5 Geht es einem Unternehmen gut, profitieren alle Interessen-gruppen. Group Management Report . The IFRS 16 “Leases” accounting standard has been applied since January 1, 2019. Patienten von Produkten, Mitarbeiter vom Einkom - men, das Gemeinwesen von Steuern. 2 GESCHÄFTSBERICHT 2012 DER NOVARTIS GRUPPE Konzernübersicht novartis bietet medizinische Lösungen an, um damit auf die sich verändernden bedürfnisse von … : +49 251 4905-0 dzhyp.de DZ HYP Geschäftsbericht 2019 in Mio. 4. Geschäftsbericht 2019 Vorwort Sehr geehrte Damen und Herren, Ihr Jörg Wieczorek - Vorsitzender - die Corona-Pandemie hat Deutsch - land, Europa und die ganze Welt vor bislang nie dagewesene Herausfor - derungen gestellt. To request a hard copy of the Annual Report, fill out the order form. The investments we made in the strategic evolution of the Group in 2019 puts SGS in a strong position as we enter the final year of our Mission 2020 and beyond. Novartis Biotechnology leadership camp organized by it is a unique step. English (PDF 5 MB) Novartis in Society ESG Report 2019 Informationen auf Deutsch. Novartis in Society US Report 2019. GESCHÄFTSBERICHT 2019 DZ HYP AG Rosenstraße 2 20095 Hamburg Tel. 31 July 2019 . Refers to continuing operations, defined on page 43 of the Condensed Financial Report. It will also ensure our industry leadership position in the TIC industry, sustainably creating long-term value for employees, customers, shareholders and for society at large. 1. € 2019 … Constant currencies (cc), core results and free cash flow are non-IFRS measures. Readers should not rely upon the information in these pages as current or accurate after their publication dates. Constant currencies (cc), core results and free cash flow are non-IFRS measures. Prior-year comparatives were not adjusted. Net revenue; 2,936.0 (in €m; adjusted) Net profit; 1,105.6 (in €m; adjusted) Dividend per share; 2.90 (in €; proposal to AGM) Employees; 6,775; with 105 nationalities; Annual report. Dabei handelt es sich um eine Augenerkrankung, die The Annual Review explains who we are and what we do, and highlights our progress against the company’s five strategic priorities in 2019. in August 2019 as plan assets to cover Deutsche Telekom’s existing pension obligations. Novartis hat in Deutschland die Initiative „Migräne muss in alle Köpfe“ ins Leben gerufen. For further information, please refer to the section “Initial application of standards, interpretations, and amendments in the financial year” in the notes to the consolidated financial statements. Our Annual Report 2019 provides a comprehensive overview of Novartis, including our corporate governance, compensation practices, and operating and financial results. The Annual Review explains who we are and what we do, and highlights our progress against the company’s five strategic priorities in 2019. Both seg-ments performed in line with expectations. «Die Tamedia AG wurde per 1. Der Aktienkurs stieg 2019 um insgesamt 84,5%, so viel wie noch nie vorher in einem Jahr. € million 2019 2018 2017 2016 2015 Auftragseingang 2453.8 2303.5 2265.3 2156.6 2261.2 Umsatz 2383.2 2245.9 2205.0 2165.7 2334.8 Auftragsbestand 1409.3 1353.9 1260.8 1200.6 Menschen bei KSB Der Erfolg von Unternehmen Novartis Institutes for BioMedical Research. Our Annual Report 2019 provides a comprehensive overview of Novartis, including our corporate governance, compensation practices, and operating and financial results. Präsident des Verwaltungsrats Novartis erzielte im Jahr 2019 ein starkes Ergebnis. Download the media presentation (PDF 1.2 MB), Download the investor presentation (PDF 3.6 MB). Geschaeftsbericht 2019_Englisch 6 24.02.2020 15:15:38. Im Jahr 2019 profitierten An explanation of non-IFRS measures can be found on page 50 of the Condensed Financial Report. Geschäftsbericht letzte 10 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 16.11.2020 — annual reports Key Figures Comparison. € auf rund 12,9 Mrd. Form 20-F documents Novartis results in line with requirements of the US Securities and Exchange Commission (SEC). Download (PDF 3.83 MB) Related Items. Plan Optik AG: Geschäftsbericht 2019 veröffentlicht DGAP-News: Plan Optik AG / Schlagwort(e): Jahresergebnis Plan Optik AG: Geschäftsbericht 2019 veröffentlicht 30.04.2020 / 14:36 Für … € Angabe 31.12.2019 31.12.2018 AKTIVA KURZFRISTIGE VERMÖGENSWERTE Zahlungsmittel und Zahlungsmitteläquivalente Forderungen aus Lieferungen und Leistungen Vertragsvermögenswerte Ertragsteuerforderungen Sonstige finanzielle Vermögenswerte Vorräte Übrige Vermögenswerte Zur Veräußerung gehaltene … RZ 190417_Geschaeftsbericht CH-Englisch-Pantone-Final_Geschäftsbericht 2015-2016 Deutsch 17.04.19 14:32 Seite 4 Novartis delivered strong performance in 2019. Wo As a major listed real estate company, we are obliged, and … The financial stake in Ströer SE & Co. KGaA was transferred to Deutsche Telekom Trust e.V. Novartis assumes no responsibility to update the information to reflect subsequent developments. Allzeithoch. Novartis bleibt auf Wachstumskurs: Nach einem starken dritten Quartal, hebt der Basler Pharmakonzern den Ausblick für das Gesamtjahr an. CEO Video Message. During 2019, Airbus presented its latest products and services at the Paris Airshow. 2.